.. .. L'enjeu-de-l'optimisation-médicamenteuse, Actions possibles, modalités de l'optimisation médicamenteuse et listes et outils disponibles

.. .. Intérêt-de-l'étude-présente,

.. .. Matériels,

.. .. Résultats, 11 2. Action de la fiche d'optimisation médicamenteuse

, 21 5. Analyse qualitative de l'intérêt

.. .. Discussion,

.. .. Conclusion,

.. .. Bibliographie,

. Enfin,

A. Corsonello, C. Pedone, and R. A. Incalzi, Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions, Curr Med Chem, vol.17, issue.6, pp.571-584, 2010.

C. Ruggiero, G. Dell'aquila, and B. Gasperini, Potentially inappropriate drug prescriptions and risk of hospitalization among older, Italian, nursing home residents: the ULISSE project. Drugs Aging, vol.27, pp.747-758, 2010.

M. E. Salive, Multimorbidity in older adults, Epidemiol Rev, vol.35, pp.75-83, 2013.

R. R. Aparasu, J. R. Mort, and H. Brandt, Polypharmacy trends in office visits by the elderly in the United States, Res Social Adm Pharm, vol.1, issue.3, pp.446-459, 1990.

P. S. Nishtala, S. W. Narayan, and T. Wang, Associations of drug burden index with falls, general practitioner visits, and mortality in older people, Pharmacoepidemiol Drug Saf, vol.23, issue.7, pp.753-758, 2014.

B. Hovstadius, K. Hovstadius, and B. Astrand, Increasing polypharmacy -an individual-based study of the Swedish population, BMC Clin Pharmacol, 2005.

A. Galazzi, M. Lusignani, and M. T. Chiarelli, Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy, Int J Clin Pharm, 2016.

S. C. Frazier, Health outcomes and polypharmacy in elderly individuals: an integrated literature review, J Gerontol Nurs, vol.31, issue.9, pp.4-11, 2005.

M. Cecile, V. Seux, and P. V. , Accidents iatrogènes médicamenteux chez le sujet âgé hospitalisé en court séjour gériatrique : étude de prévalence et des facteurs de risques, Rev Med Interne, vol.30, issue.5, pp.393-400, 2009.

V. Sehgal, S. J. Bajwa, and R. Sehgal, Polypharmacy and potentially inappropriate medication use as the precipitating factor in readmissions to the hospital, J Family Med Prim Care, vol.2, issue.2, pp.194-199, 2013.

N. Fouchera, Iatrogénie médicamenteuse chez les patients âgés admis en service d'urgences. Le Pharmacien Hospitalier et Clinicien, vol.47, pp.1-10, 2012.

B. Hovstadius and G. Petersson, The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden, 2005.

C. Lafuente-lafuente, E. Baudry, and E. Paillaud, Prescription des médicaments chez les personnes âgées : des améliorations sont nécessaires, Presse Med, vol.42, pp.168-170, 2013.

T. R. Fried, J. O'leary, and V. Towle, Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review, J Am Geriatr Soc, vol.62, issue.12, pp.2261-2272, 2014.

H. Autorité-de-santé, Consommation médicamenteuse chez le sujet âgé : Consommation, Prescription, Iatrogénie et Observance, HAS, 2005.

M. Lachamp, V. Pauly, and R. Sambuc, Impact de la modification des prescriptions chez les sujets âgés hospitalisés en service de court séjour gériatrique en termes de coût, Rev Med Interne, vol.33, issue.9, pp.482-490, 2012.

S. Ministère-des, L. De, and . Santé, L'état de santé de la population en France -RAPPORT, 2017.

H. Autorité-de-santé, Prescription Médicamenteuse chez le Sujet Agé (PMSA) -Programme Pilote, 2006.

D. Veauvy, Introduction à la rationalisation de la pharmacothérapie chez le sujet âgé, NPG, vol.11, pp.41-45, 2011.

J. T. Hanlon and K. E. Schmader, The medication appropriateness index at 20: where it started, where it has been, and where it may be going, Drugs Aging, 2013.

C. M. Campanelli, American Geriatrics Society Updated Beers criteria for potentially inappropriate medication use in older adults: The American Geriatrics Society, 2012.

, Beers Criteria Update Expert Panel, J Am Geriatr Soc, vol.60, issue.4, pp.616-631, 2012.

M. L. Laroche, F. Bouthier, and M. L. , Médicaments potentiellement inappropriés aux personnes âgées : intérêt d'une liste adaptée à la pratique médicale française

, La Revue de médecine interne, vol.30, pp.592-601, 2009.

P. Gallagher, C. Ryan, and S. Byrne, STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment)

, Consensus validation, Int J Clin Pharmacol Ther, vol.46, issue.2, pp.72-83, 2008.

P. O. Lang, Y. Hasso, and J. Belmin, STOPP-START : adaptation of a French language screening tool for detecting inappropriate prescriptions in older people, Can J Public Health, vol.100, issue.6, pp.426-431, 2009.

P. O. Lang and . Stopp-start, du nouveau dans la détection des prescriptions médicamenteuses inappropriées dans la population âgée, vol.35, pp.341-348, 2010.

H. Hamilton, P. Gallagher, and C. Ryan, Potentially Inappropriate Medications Defined by STOPP Criteria and the Risk of Adverse Drug Events in Older Hospitalized Patients, Arch Intern Med, vol.171, issue.11, pp.1013-1019, 2011.

D. O'mahony and . Stopp-&, START criteria: a new approach to detecting potentially inappropriate prescribing in old age, Eur Geriatr Med, vol.1, pp.45-51, 2010.

C. M. Curtain, I. K. Bindoff, and J. L. Westbury, A comparison of prescribing criteria when applied to older community-based patients, Drugs Aging, 2013.

M. P. Lam and B. M. Cheung, The use of STOPP/START criteria as a screening tool for assessing the appropriatness of medications in the elderly population, Expert Rev Clin Pharmacol, vol.5, pp.187-197, 2012.

P. O. Lang, M. Dramé, and B. Guignard, STOPP/START.v2 criteria : Adaptation into French Language, NPG, vol.15, pp.323-336, 2015.

J. C. Naveiro-rilo, D. Diez-juárez, and M. L. Flores-zurutuza, Intervention in elderly patients with multiple morbidities and multiple medications: Results of the prescription and the quality of life, Rev Calid Asist, vol.29, issue.5, pp.256-262, 2014.

O. Dalleur, J. M. Feron, and A. Spinewine, Views of general practitioners on the use of STOPP&START in primary care: a qualitative study, Acta Clin Belg, 2014.

A. Spinewine, K. E. Schmader, and N. Barber, Appropriate prescribing in elderly people: how well can it be measured and optimised?, Lancet, 2007.

J. T. Hanlon, M. Weinberger, and G. P. Samsa,

M. Crotty, D. Rowett, and L. Spurling, long-term care facility? Results of a randomized, controlled trial, Am J Geriatr Pharmacother, vol.2, pp.257-264, 2004.

K. E. Schmader, J. T. Hanlon, and C. F. Pieper, Effects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderly, Am J Med, vol.116, issue.6, pp.394-401, 2004.

I. Saltvedt, O. Spigset, and S. Ruths, Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study, Eur J Clin Pharmacol, vol.61, issue.12, pp.921-928, 2005.

M. Crotty, J. Halbert, and D. Rowett, An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing

, Age Ageing, issue.6, pp.612-617, 2004.

S. Meredith, P. Feldman, and D. Frey, Improving medication use in newly admitted home healthcare patients: a randomized controlled trial, J Am Geriatr Soc, 2002.

O. Dalleur, B. Boland, and C. Losseau, Reduction of potentially inappropriate medications using the STOPP criteria in frail older inpatients: a randomised controlled study, Drugs Aging, vol.31, issue.4, pp.291-298, 2014.

P. F. Gallagher, M. N. O'connor, O. 'mahony, and D. , Prevention of Potentially Inappropriate Prescribing for Elderly Patients: A Randomized Controlled Trial Using STOPP/START Criteria, Clin Pharmacol Ther, vol.89, issue.6, pp.845-854, 2011.

J. L. Kwan, L. Lo, and M. Sampson, Medication reconciliation during transitions of care as a patient safety strategy: a systematic review, Ann Intern Med, vol.158, pp.397-403, 2013.

P. Kirchhof, S. Benussi, and D. Kotecha, ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS, Eur Heart J, 2016.

, Oct, vol.7, issue.38, pp.2893-2962

I. Saltvedt, O. Spigset, and S. Ruths, Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study, Eur J Clin Pharmacol, vol.61, issue.12, pp.921-928, 2005.

T. Jörgensen, S. Johansson, and A. Kennerfalk, Prescription drug use, diagnoses, and healthcare utilization among the elderly, Ann Pharmacother, 2001.

S. I. Haider, K. Johnell, and G. R. Weitoft, The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people, J Am Geriatr Soc, vol.57, issue.1, pp.62-69, 2009.

K. K. Viktil, H. S. Blix, and T. A. Moger, Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems, Br J Clin Pharmacol, vol.63, issue.2, pp.187-195, 2007.

A. Langeard, K. Pothier, and R. Morello, Polypharmacy Cut-Off for Gait and Cognitive Impairments, Front. Pharmacol, vol.7, p.296, 2016.
URL : https://hal.archives-ouvertes.fr/inserm-02135138

S. H. Preskorn, B. Silkey, and R. Shah, Complexity of medication use in the Veterans Affairs healthcare system: Part I: Outpatient use in relation to age and number of prescribers, J Psychiatr Pract, vol.11, issue.1, pp.5-15, 2005.

M. A. Steinman, C. S. Landefeld, and G. E. Rosenthal, Polypharmacy and prescribing quality in older people, J Am Geriatr Soc, vol.54, issue.10, pp.1516-1523, 2006.

O. Dalleur, A. Spinewine, and S. Henrard, Inappropriate Prescribing and Related Hospital Admissions in Frail Older Persons According to the STOPP and START Criteria, Drugs Aging, vol.29, pp.829-837, 2012.

P. J. Barry, P. Gallagher, and C. Ryan, START (screening tool to alert doctors to the right treatment) -an evidence-based screening tool to detect prescribing omissions in elderly patients, Age and Ageing, vol.36, pp.632-638, 2007.

, Projet OMAGE : un nouveau soin transitionnel pour diminuer les ré-hospitalisations des sujets âgés, 2017.

M. N. O'connor, O. 'sullivan, D. Gallagher, and P. F. , Prevention of hospital-acquired adverse drug reactions in older people using Screening Tool of Older Persons' Prescriptions and Screening Tool to Alert to Right Treatment criteria : a cluster randomized controlled trial, Critères STOPP/START. Version, vol.64, p.46, 2015.

, Annexe 2 : Fiche d'Optimisation Médicamenteuse